BPC-157 exhibits promising anti-cancer properties by suppressing tumor growth, inhibiting angiogenesis, modulating the immune system, and protecting against chemotherapy-induced toxicity
Chronic B12 deficiency patients require indefinite therapy with regular monitoring
Based on current evidence, some other Clostridium species (e.g., Clostridium difficile ) may contribute to ADs by disrupting gut microbial homeostasis, secreting exotoxins, or exacerbating intestinal barrier dysfunction
What is this product used for
VEGF-R2 axis / local angiogenesis BPC-157 upregulates VEGF-R2 (KDR) receptor expression on vascular endothelium at the lesion site, triggering early neoangiogenesis required for tendon and ligament repair (Sikiric 2018, successive reviews)
Adjustments are common and expected peptide therapy is precision medicine, not one-size-fits-all